5VWD
HLA-B*57:03 presenting LTVQVARVW
Experimental procedure
Experimental method | SINGLE WAVELENGTH |
Source type | SYNCHROTRON |
Source details | AUSTRALIAN SYNCHROTRON BEAMLINE MX2 |
Synchrotron site | Australian Synchrotron |
Beamline | MX2 |
Temperature [K] | 100 |
Detector technology | CCD |
Collection date | 2015-10-05 |
Detector | ADSC QUANTUM 315 |
Wavelength(s) | 0.954 |
Spacegroup name | P 21 21 21 |
Unit cell lengths | 50.895, 81.939, 109.783 |
Unit cell angles | 90.00, 90.00, 90.00 |
Refinement procedure
Resolution | 31.914 - 1.800 |
R-factor | 0.1727 |
Rwork | 0.171 |
R-free | 0.20780 |
Structure solution method | MOLECULAR REPLACEMENT |
Starting model (for MR) | 2rfx |
RMSD bond length | 0.003 |
RMSD bond angle | 0.774 |
Data reduction software | MOSFLM |
Data scaling software | SCALA |
Phasing software | PHASER |
Refinement software | PHENIX (1.9_1690) |
Data quality characteristics
Overall | Outer shell | |
Low resolution limit [Å] | 31.914 | 1.900 |
High resolution limit [Å] | 1.800 | 1.800 |
Rmerge | 0.140 | |
Number of reflections | 43277 | 6224 |
<I/σ(I)> | 10.1 | 2.7 |
Completeness [%] | 99.8 | 99.4 |
Redundancy | 6.6 | 6.5 |
Crystallization Conditions
crystal ID | method | pH | temperature | details |
1 | VAPOR DIFFUSION, HANGING DROP | 5.4 | 298 | 12 -20 % PEG 4000, 0.2 M ammonium acetate and 0.1 M tri-sodium citrate pH 5.4 |